Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection and prevention of cancer, will showcase its latest software advancements at the Annual Radiological Society of North America (RSNA) meeting, November 26-29, 2023 (South Hall, Booth #2780). Volpara's enhancements to its software portfolio embrace the meeting's theme of "Leading Through Change."  The company's Risk Pathways® solution helps

NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd. and a pioneer in premium diagnostic imaging solutions, will showcase its latest offerings in mobile computed tomography (CT) and feature the OmniTom® Elite Photon Counting mobile CT scanner at the Radiological Society of North America (RSNA) Annual Meeting in Chicago from November 26 to November 30. The clinical launch of the OmniTom Elite with PCD, the first US FDA 510(k) cleared single-source photon counting compu

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced that three scientific sessions highlighting ultra-low-field imaging data will be presented at the Radiological Society of North America (RSNA) 2023 Annual Meeting in Chicago. These studies analyzed how portable MR brain imaging may

Venus Medtech is changing how the world treats structural heart disease. The company will present its products at its booth (#28), during two symposia, in multiple podium presentations and at a special cocktail reception where it will officially launch the SMART-ALIGN multicenter clinical study. Structural heart symposia on November 20 and 21 The company will be hosting two symposia on November 20 and 21 that will allow interventional cardiologists to deep

The University of Wisconsin School of Medicine and Public Health at UW–Madison and GE HealthCare announced today a 10-year strategic collaboration that builds on an iconic relationship spanning more than 40 years. The new research collaboration expands the existing scope beyond medical imaging to new frontiers in digital technologies and disease-focused solutions. Combining UW–Madison’s world-class team of physicians, scientists, and researchers with GE HealthCare&

BioIntelliSense, a continuous health monitoring and clinical intelligence company, and California-based UC Davis Health announce the launch of a new in-hospital monitoring initiative for patients hospitalized for Bone Marrow Transplant and Hematology/Oncology services. The transformational program leverages the BioIntelliSense FDA-cleared BioButton® wearable devices, algorithmic-based data analytics, and clinical intelligence system to monitor for subtle changes in vital sign trends and s

Regent Surgical Health (“Regent” or the “Company”), a national platform of ambulatory surgery centers specializing in health system joint venture partnerships, announced today that it has expanded its successful joint venture partnership with Oregon Surgical Institute (OSI). As a result of the agreement, Regent has gained majority ownership of OSI, an internationally recognized outpatient surgery center specializing in complex cases. “Regent’s inc

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the close of its acquisition of LimFlow S.A., a privately-held pioneer in limb salvage for patients with chronic limb-threatening ischemia (CLTI). “The close of the LimFlow acquisition allows us to begin to integrate this exciting technology that is offering new hope to patients

Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of its JAWS™ Great White Staple System which was developed to provide for increased strength and stability of the osteotomy or fusion site when compared to traditional staple systems. The staples feature an ultra-low-profile bridge with increased surface area to enhance stability while minimizing soft tissue irritation. The newly designed staple has 400 times the fatigue life compared to a competitive nitinol staple subjecte

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today the validation and launch of a new method of collecting blood specimens for Nodify Lung Nodule Risk Assessment testing. The method uses the FDA-cleared Tasso+™ device, a single-use blood lancing device intended for obtaining capillary whole blood samples from a patient’s upper arm. Blood-based Nodify Lung testing, comprised of the Nodify CDT® and Nodify